Merck Considers Returning Vioxx to Marketplace
In spite of the recent victory for Vioxx plaintiffs in Texas, Merck continues to flirt with the idea of returning Vioxx to the market. The FDA will only allow this if the drug's use is limited and heavy warnings are added to its label.
The problem is the real reason Merck may return the drug to the market is so that plaintiff's attorney may not use the withdrawal of the drug from the market as ammunition for their courtroom arguments. In reality, the overall effect of plaintiff's arguments would be effected little. However, the risk the drug may pose to citizens if it is returned to the marketplace is significant.
Read the full article here.
I enjoyed reading your stuff. Cool site.
Post A Comment / Question